Reproductive function after treatment of malignant germ cell ovarian tumors

Molecular and Cellular Endocrinology

Volumn 202, Issue 1-2, 2003, Pages 117-121

  Sagae, Satoru ^a   Sasaki, Hiroshi ^b   Nishioka, Yoshihiro ^a   Terasawa, Katsuhiko ^a   Kudo, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Conservative surgery; Fertility; Ovarian germ cell tumor; Reproductive function

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONCEPTION; CONFERENCE PAPER; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; INFERTILITY; MENSTRUATION; OVARY TUMOR; PREGNANCY TERMINATION; PRIORITY JOURNAL; REPRODUCTION; SCHOOL CHILD; TERATOMA; YOLK SAC TUMOR;

EID: 0038288732     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00072-8     Document Type: Conference Paper

References (28)

1. Bahamondes L., Vera S., Geraldo Romanello J., Pimentel E., Hardy E., Ramos M. Identification of main risk factors for tubal infertility. Fertil. Steril. 61:1994;478-482.
2. Barki Y.N., Given F.T. Normal pregnancy and following conservative surgery and chemotherapy for ovarian endodermal sinus tumor. Gynecol. Oncol. 19:1984;222-225.
3. Brewer M., Gershenson D.M., Herzog C.E., Mitchell M.F., Silva E.G., Wharton J.T. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J. Clin. Oncol. 17:1999;2670-2675.
4. Casey A.C., Bhodauria S., Shapter A., Nieberg R., Berek J.S., Farias-Eisner R. Dysgerminoma: the role of conservative surgery. Gynecol. Oncol. 63:1996;352-357.
5. Chapman R.M., Sutcliffe S.B. Protection of ovarian function by oral contraceptives in women receiving chemotherapy. Blood. 58:1981;849-851.
6. Creasman W.T., Soper J.T. Assessment of the contemporary management of germ cell malignancies of the ovary. Am. J. Obstet. Gynecol. 153:1985;828-834.
7. Curtin J.P., Adcock L.L. Pregnancy following treatment of endodermal sinus tumor of the ovary with combination chemotherapy, including cis-platinum. Gynecol. Oncol. 24:1986;268-270.
8. Dark G.G., Bower M., Newlands E.S., Paradinos F., Rustin G.L.S. Surveillance policy for stage I ovarian germ cell tumors. J. Clin. Oncol. 15:1997;620-624.
9. Dodds L., Marrett I.D., Tomkins D.J., Green B., Sherman G. Case-control study of congenital anomalies in children of cancer patients. Br. Med. J. 307:1993;164-168.
10. Donnez J., Godin P.-A., Qu J., Nisolle M. Gonadal Cryopreservation in the young patient with gynaecological malignancy. Curr. Opin. Obstet. Gynecol. 12:2000;1-9.
11. Feldman J.E. Ovarian failure and cancer treatment: incidence and interventions for the premenopausal woman. Oncol. Nurs. Forum. 16:1989;651-657.
12. Staging announcement: Gynecol. Oncol. 25:1986;383-385.
13. Fishman D.A., Schawartz P.E. Current approach to diagnosis and treatment of ovarian germ cell malignancies. Curr. Opin. Obstet. Gynecol. 6:1994;98-104.
14. Gershenson D.M. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J. Clin. Oncol. 6:1988;270-275.
15. Gershenson D.M. Update on malignant ovarian germ cell tumors. Cancer. 71:1993;1581-1590.
16. Hawkins M.M. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J. Natl. Cancer Inst. 83:1991;1643-1650.
17. Kawai M., Furuhashi Y., Kano T., Misawa T., Nakashima N., Hattori S., Okamoto Y., Kobayashi I., Ohta M., Arii Y., Tomoda Y. AFP in malignant germ cell tumors of the ovary. Gynecol. Oncol. 39:1990;160-166.
18. Kreuser E.D., Klingmuller D., Thiel E. The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation. Eur. Urol. 23:1993;157-163.
19. Myers S.E., Schilsky R.L. Prospects for fertility after cancer chemotherapy. Semin. Oncol. 19:1992;597-604.
20. Low J.J.H., Perrin L.C., Crandon A.J., Hacker N.F. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors a review of 74 cases. Cancer. 89:2000;391-398.
21. Peccatori F., Bonazzi C., Chiari S., Landoni F., Colombo N., Mangioni C. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet. Gynecol. 86:1995;367-372.
22. Pektasides D., Rustin G.J., Newlands E.S., Begent R.H., Bagshawe K.D. Fertility after chemotherapy for ovarian germ cell tumors. Br. J. Obstet. Gynaecol. 94:1987;477-479.
23. Scully R.E., Sobin L.N. Histological typing of ovarian tumors. World Health Organization International classification of tumors. 2nd ed. 1999;28-36 Springer, New York.
24. Shima Y. Quantitative study of the effect of oncostatic toxicity on murine fertility. Acta Obstet. Gynaecol. Jpn. 46:1994;589-596.
25. Shiromizu K., Kawana T., Sugase M., Takizawa K., Kawagoe K., Izumi R., Mizuno M. Pregnancies following conservative treatment of malignant ovarian tumors. Arch. Gynecol. Obstet. 241:1987;57-62.
26. Takizawa K., Yokoo I., Shima Y., Inou Y., Sato M., Iguchi T., Takeda Y. Quantitative evaluation for murine oocyte toxicity following intraperitoneal treatment with chemotherapeutic agents. Acta Obstet. Gynaec. Jpn. 41:1989;715-722.
27. Whitehead E., Shalet S.M., Blackledge G., Todd I., Crowther D., Beardwell C.G. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 52:1983;988-993.
28. Zanetta G., Bonazzi C., Cantu M.G., Bini S., Locatelli A., Bretina G., Mangioni C. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J. Clin. Oncol. 19:2001;1015-1020.